ALVO – alvotech - ordinary shares (US:NASDAQ)
Stock Stats
News
Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation - ALVO
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Alvotech (NASDAQ:ALVO) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Alvotech announces European launch of biosimilar to Simponi [Seeking Alpha]
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma [Yahoo! Finance]
Form 6-K Alvotech For: Dec 22
Form 6-K Alvotech For: Dec 19
Form 6-K Alvotech For: Dec 17
Form 6-K Alvotech For: Nov 24
Form 6-K Alvotech For: Nov 20
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.